GC-MS Techniques Investigating Potential Biomarkers of Dying in the Last Weeks with Lung Cancer

Predicting when a patient with advanced cancer is dying is a challenge and currently no prognostic test is available. We hypothesised that a dying process from cancer is associated with metabolic changes and specifically with changes in volatile organic compounds (VOCs). We analysed urine from patie...

Full description

Bibliographic Details
Main Authors: Elinor A. Chapman, James Baker, Prashant Aggarwal, David M. Hughes, Amara C. Nwosu, Mark T. Boyd, Catriona R. Mayland, Stephen Mason, John Ellershaw, Chris S. Probert, Séamus Coyle
Format: Article
Language:English
Published: MDPI AG 2023-01-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/24/2/1591
_version_ 1797441170351063040
author Elinor A. Chapman
James Baker
Prashant Aggarwal
David M. Hughes
Amara C. Nwosu
Mark T. Boyd
Catriona R. Mayland
Stephen Mason
John Ellershaw
Chris S. Probert
Séamus Coyle
author_facet Elinor A. Chapman
James Baker
Prashant Aggarwal
David M. Hughes
Amara C. Nwosu
Mark T. Boyd
Catriona R. Mayland
Stephen Mason
John Ellershaw
Chris S. Probert
Séamus Coyle
author_sort Elinor A. Chapman
collection DOAJ
description Predicting when a patient with advanced cancer is dying is a challenge and currently no prognostic test is available. We hypothesised that a dying process from cancer is associated with metabolic changes and specifically with changes in volatile organic compounds (VOCs). We analysed urine from patients with lung cancer in the last weeks of life by headspace gas chromatography mass spectrometry. Urine was acidified or alkalinised before analysis. VOC changes in the last weeks of life were identified using univariate, multivariate and linear regression analysis; 12 VOCs increased (11 from the acid dataset, 2 from the alkali dataset) and 25 VOCs decreased (23 from the acid dataset and 3 from the alkali dataset). A Cox Lasso prediction model using 8 VOCs predicted dying with an AUC of 0.77, 0.78 and 0.85 at 30, 20 and 10 days and stratified patients into a low (median 10 days), medium (median 50 days) or high risk of survival. Our data supports the hypothesis there are specific metabolic changes associated with the dying. The VOCs identified are potential biomarkers of dying in lung cancer and could be used as a tool to provide additional prognostic information to inform expert clinician judgement and subsequent decision making.
first_indexed 2024-03-09T12:19:08Z
format Article
id doaj.art-b5806f459bb947deb4d78b7b2197aa5e
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-09T12:19:08Z
publishDate 2023-01-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-b5806f459bb947deb4d78b7b2197aa5e2023-11-30T22:42:44ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672023-01-01242159110.3390/ijms24021591GC-MS Techniques Investigating Potential Biomarkers of Dying in the Last Weeks with Lung CancerElinor A. Chapman0James Baker1Prashant Aggarwal2David M. Hughes3Amara C. Nwosu4Mark T. Boyd5Catriona R. Mayland6Stephen Mason7John Ellershaw8Chris S. Probert9Séamus Coyle10School of Medical and Health Sciences, Bangor University, Bangor LL57 2DG, UKInstitute of Systems Medicine and Integrative Biology, University of Liverpool, Liverpool L69 7BE, UKInstitute of Systems Medicine and Integrative Biology, University of Liverpool, Liverpool L69 7BE, UKDepartment of Health Data Science, University of Liverpool, Liverpool L69 3GF, UKAcademic Palliative & End of Life Care Department, Liverpool University Hospitals NHS Foundation Trust, Liverpool L7 8XP, UKInstitute of Systems Medicine and Integrative Biology, University of Liverpool, Liverpool L69 7BE, UKDepartment of Oncology and Metabolism, University of Sheffield, Sheffield S10 2RX, UKPalliative Care Unit, Institute of Life Course & Medical Sciences, University of Liverpool, Liverpool L7 8TX, UKAcademic Palliative & End of Life Care Department, Liverpool University Hospitals NHS Foundation Trust, Liverpool L7 8XP, UKInstitute of Systems Medicine and Integrative Biology, University of Liverpool, Liverpool L69 7BE, UKLiverpool Head and Neck Cancer Centre, University of Liverpool, Liverpool L69 3BX, UKPredicting when a patient with advanced cancer is dying is a challenge and currently no prognostic test is available. We hypothesised that a dying process from cancer is associated with metabolic changes and specifically with changes in volatile organic compounds (VOCs). We analysed urine from patients with lung cancer in the last weeks of life by headspace gas chromatography mass spectrometry. Urine was acidified or alkalinised before analysis. VOC changes in the last weeks of life were identified using univariate, multivariate and linear regression analysis; 12 VOCs increased (11 from the acid dataset, 2 from the alkali dataset) and 25 VOCs decreased (23 from the acid dataset and 3 from the alkali dataset). A Cox Lasso prediction model using 8 VOCs predicted dying with an AUC of 0.77, 0.78 and 0.85 at 30, 20 and 10 days and stratified patients into a low (median 10 days), medium (median 50 days) or high risk of survival. Our data supports the hypothesis there are specific metabolic changes associated with the dying. The VOCs identified are potential biomarkers of dying in lung cancer and could be used as a tool to provide additional prognostic information to inform expert clinician judgement and subsequent decision making.https://www.mdpi.com/1422-0067/24/2/1591GC-MSlung cancerdyingurineVOCsvolatile
spellingShingle Elinor A. Chapman
James Baker
Prashant Aggarwal
David M. Hughes
Amara C. Nwosu
Mark T. Boyd
Catriona R. Mayland
Stephen Mason
John Ellershaw
Chris S. Probert
Séamus Coyle
GC-MS Techniques Investigating Potential Biomarkers of Dying in the Last Weeks with Lung Cancer
International Journal of Molecular Sciences
GC-MS
lung cancer
dying
urine
VOCs
volatile
title GC-MS Techniques Investigating Potential Biomarkers of Dying in the Last Weeks with Lung Cancer
title_full GC-MS Techniques Investigating Potential Biomarkers of Dying in the Last Weeks with Lung Cancer
title_fullStr GC-MS Techniques Investigating Potential Biomarkers of Dying in the Last Weeks with Lung Cancer
title_full_unstemmed GC-MS Techniques Investigating Potential Biomarkers of Dying in the Last Weeks with Lung Cancer
title_short GC-MS Techniques Investigating Potential Biomarkers of Dying in the Last Weeks with Lung Cancer
title_sort gc ms techniques investigating potential biomarkers of dying in the last weeks with lung cancer
topic GC-MS
lung cancer
dying
urine
VOCs
volatile
url https://www.mdpi.com/1422-0067/24/2/1591
work_keys_str_mv AT elinorachapman gcmstechniquesinvestigatingpotentialbiomarkersofdyinginthelastweekswithlungcancer
AT jamesbaker gcmstechniquesinvestigatingpotentialbiomarkersofdyinginthelastweekswithlungcancer
AT prashantaggarwal gcmstechniquesinvestigatingpotentialbiomarkersofdyinginthelastweekswithlungcancer
AT davidmhughes gcmstechniquesinvestigatingpotentialbiomarkersofdyinginthelastweekswithlungcancer
AT amaracnwosu gcmstechniquesinvestigatingpotentialbiomarkersofdyinginthelastweekswithlungcancer
AT marktboyd gcmstechniquesinvestigatingpotentialbiomarkersofdyinginthelastweekswithlungcancer
AT catrionarmayland gcmstechniquesinvestigatingpotentialbiomarkersofdyinginthelastweekswithlungcancer
AT stephenmason gcmstechniquesinvestigatingpotentialbiomarkersofdyinginthelastweekswithlungcancer
AT johnellershaw gcmstechniquesinvestigatingpotentialbiomarkersofdyinginthelastweekswithlungcancer
AT chrissprobert gcmstechniquesinvestigatingpotentialbiomarkersofdyinginthelastweekswithlungcancer
AT seamuscoyle gcmstechniquesinvestigatingpotentialbiomarkersofdyinginthelastweekswithlungcancer